KYC is one time exercise with a SEBI registered intermediary while dealing in securities markets (Broker/ DP/ Mutual Fund etc.). | No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.   |   Prevent unauthorized transactions in your account – Update your mobile numbers / email ids with your stock brokers. Receive information of your transactions directly from exchange on your mobile / email at the EOD | Filing Complaint on SCORES - QUICK & EASY a) Register on SCORES b) Mandatory details for filing complaints on SCORE - Name, PAN, Email, Address and Mob. no. c) Benefits - speedy redressal & Effective communication   |   BSE Prices delayed by 5 minutes...<< Prices as on Sep 25, 2026 - 3:59PM >>  ABB India 7057.9  [ -0.80% ]  ACC 1235.1  [ -0.13% ]  Ambuja Cements 384.75  [ -0.32% ]  Asian Paints 2445  [ 1.93% ]  Axis Bank 1220  [ 2.82% ]  Bajaj Auto 11340  [ 1.20% ]  Bank of Baroda 235.25  [ 0.30% ]  Bharti Airtel 1786.9  [ -0.23% ]  Bharat Heavy 419.2  [ 0.77% ]  Bharat Petroleum 307.55  [ -0.11% ]  Britannia Industries 4939  [ 0.18% ]  Cipla 1397.2  [ -0.48% ]  Coal India 425.3  [ 0.81% ]  Colgate Palm 1854.2  [ -0.14% ]  Dabur India 386.95  [ 0.47% ]  DLF 680.5  [ 1.46% ]  Dr. Reddy's Lab. 1202.8  [ 0.20% ]  GAIL (India) 172.65  [ -0.60% ]  Grasim Industries 3182  [ 0.28% ]  HCL Technologies 1259.4  [ 1.17% ]  HDFC Bank 735.8  [ 0.87% ]  Hero MotoCorp 5353  [ 1.36% ]  Hindustan Unilever 1940  [ 0.36% ]  Hindalco Industries 976.1  [ -0.70% ]  ICICI Bank 1326.5  [ -0.41% ]  Indian Hotels Co. 726  [ -0.34% ]  IndusInd Bank 912.5  [ -0.84% ]  Infosys 1000.95  [ -0.81% ]  ITC 269  [ 0.45% ]  Jindal Steel 1165  [ 0.92% ]  Kotak Mahindra Bank 403.4  [ -0.47% ]  L&T 3879  [ 0.88% ]  Lupin 2090  [ -0.38% ]  Mahi. & Mahi 3031.35  [ 2.24% ]  Maruti Suzuki India 12071  [ 0.48% ]  MTNL 23.61  [ -0.96% ]  Nestle India 1364.9  [ 0.87% ]  NIIT 88.2  [ -1.95% ]  NMDC 80  [ -1.05% ]  NTPC 326.2  [ -0.09% ]  ONGC 235.55  [ -1.01% ]  Punj. NationlBak 116.7  [ -0.30% ]  Power Grid Corpn. 269.25  [ 0.84% ]  Reliance Industries 1226  [ 0.57% ]  SBI 982.5  [ 0.41% ]  Vedanta 265.7  [ -0.84% ]  Shipping Corpn. 273  [ -1.28% ]  Sun Pharmaceutical 1853.5  [ 0.03% ]  Tata Chemicals 644.1  [ -1.23% ]  Tata Consumer 983  [ -0.28% ]  Tata Motors Passenge 290.3  [ -1.79% ]  Tata Steel 187.7  [ -0.37% ]  Tata Power Co. 366.8  [ 0.77% ]  Tata Consult. Serv. 2083.95  [ 0.33% ]  Tech Mahindra 1547  [ 0.06% ]  UltraTech Cement 11100  [ 0.17% ]  United Spirits 1422.15  [ -0.22% ]  Wipro 164.15  [ 0.34% ]  Zee Entertainment 76.93  [ -1.60% ]  
  • Share Prices
  • Tools
  • News
  • Company Details
  • Financial Data
  • Results
  • Key Financial Ratios
  • Reports
  • Corporate Announcements
  • Equity History

    • Company Information

    Indian Indices
    • Loading....

    Global Indices
    • Loading....

    Forex
    • Loading....

    GUJARAT INJECT (KERALA) LTD.

    25 September 2026 | 04:01

    Industry >> Pharmaceuticals

    Select Another Company

    ISIN No INE659F01022 BSE Code / NSE Code 524238 / GUJINJEC Book Value (Rs.) 0.81 Face Value 1.00
    Bookclosure 08/07/2026 52Week High 14 EPS 0.12 P/E 76.74
    Market Cap. 139.17 Cr. 52Week Low 2 P/BV / Div Yield (%) 11.75 / 0.00 Market Lot 1.00
    Security Type Other
    • Select another Company

    Quarterly Trends

    Gujarat Inject (Kerala) Ltd. Aarey Drugs & Pharmaceuticals Ltd.
    Year Ends (Months) 202606(3) 202603(3) 202606(3) 202603(3)
    OprtIncome Gujarat Inject (Kerala) Ltd. 12.45 30.70 Aarey Drugs & Pharmaceuticals Ltd. 44.63 189.47
    OtherRecurrInc Gujarat Inject (Kerala) Ltd. 0.00 0.00 Aarey Drugs & Pharmaceuticals Ltd. 1.72 -0.43
    Operating profit Gujarat Inject (Kerala) Ltd. 1.69 2.27 Aarey Drugs & Pharmaceuticals Ltd. 0.48 3.49
    GrossProfit Gujarat Inject (Kerala) Ltd. 0.00 0.00 Aarey Drugs & Pharmaceuticals Ltd. 0.00 0.00
    ReportedPAT Gujarat Inject (Kerala) Ltd. 1.25 1.64 Aarey Drugs & Pharmaceuticals Ltd. 1.02 1.56
    Equity Capital Gujarat Inject (Kerala) Ltd. 14.63 14.63 Aarey Drugs & Pharmaceuticals Ltd. 28.45 28.45
    OPM Gujarat Inject (Kerala) Ltd. 13.55 7.37 Aarey Drugs & Pharmaceuticals Ltd. 1.06 1.84
    GPM Gujarat Inject (Kerala) Ltd. 0.00 0.00 Aarey Drugs & Pharmaceuticals Ltd. 0.00 0.00
    NPM Gujarat Inject (Kerala) Ltd. 10.04 0.00 Aarey Drugs & Pharmaceuticals Ltd. 2.29 0.82

    Annual Trends

    Gujarat Inject (Kerala) Ltd. Aarey Drugs & Pharmaceuticals Ltd.
    Year Ends (Months) 202603(12) 202503(12) 202603(12) 202503(12)
    OperatingIncome Gujarat Inject (Kerala) Ltd. 36.32 19.05 Aarey Drugs & Pharmaceuticals Ltd. 472.27 473.94
    OperatingProfit Gujarat Inject (Kerala) Ltd. 2.31 1.08 Aarey Drugs & Pharmaceuticals Ltd. 7.17 2.90
    OtherRecurrInc Gujarat Inject (Kerala) Ltd. 0.20 0.18 Aarey Drugs & Pharmaceuticals Ltd. 6.10 9.81
    AdjustedPBT Gujarat Inject (Kerala) Ltd. 2.50 1.25 Aarey Drugs & Pharmaceuticals Ltd. 5.41 6.10
    ReportedPAT Gujarat Inject (Kerala) Ltd. 1.81 1.02 Aarey Drugs & Pharmaceuticals Ltd. 3.97 4.02
    EquityDividend Gujarat Inject (Kerala) Ltd. 0.00 0.00 Aarey Drugs & Pharmaceuticals Ltd. 0.00 0.00
    EquityCapital Gujarat Inject (Kerala) Ltd. 14.63 14.63 Aarey Drugs & Pharmaceuticals Ltd. 28.45 28.45
    PreferenceCapital Gujarat Inject (Kerala) Ltd. 0.00 0.00 Aarey Drugs & Pharmaceuticals Ltd. 0.00 0.00
    ResAndSurplus Gujarat Inject (Kerala) Ltd. -2.80 -4.62 Aarey Drugs & Pharmaceuticals Ltd. 121.97 107.51
    LoanFunds Gujarat Inject (Kerala) Ltd. 0.00 0.00 Aarey Drugs & Pharmaceuticals Ltd. 49.96 34.86
    AL_CurrentLiabilities Gujarat Inject (Kerala) Ltd. 24.84 1.94 Aarey Drugs & Pharmaceuticals Ltd. 96.86 117.26
    NetBlock Gujarat Inject (Kerala) Ltd. 20.76 0.00 Aarey Drugs & Pharmaceuticals Ltd. 25.78 16.22
    Investments Gujarat Inject (Kerala) Ltd. 0.00 0.00 Aarey Drugs & Pharmaceuticals Ltd. 2.12 2.12
    TotCurrentAssets Gujarat Inject (Kerala) Ltd. 15.90 11.95 Aarey Drugs & Pharmaceuticals Ltd. 269.35 272.26

    Ratios

    Gujarat Inject (Kerala) Ltd. Aarey Drugs & Pharmaceuticals Ltd.
    Year Ends (Months) 202603(12) 202503(12) 202603(12) 202503(12)
    OPM Gujarat Inject (Kerala) Ltd. 6.35 5.64 Aarey Drugs & Pharmaceuticals Ltd. 1.51 0.61
    NPM Gujarat Inject (Kerala) Ltd. 4.99 5.34 Aarey Drugs & Pharmaceuticals Ltd. 0.84 0.84
    Reported EPS Gujarat Inject (Kerala) Ltd. 1.24 0.69 Aarey Drugs & Pharmaceuticals Ltd. 1.39 1.43
    Return on Networth Gujarat Inject (Kerala) Ltd. 15.33 10.15 Aarey Drugs & Pharmaceuticals Ltd. 2.63 2.95
    Debt/ Equity Gujarat Inject (Kerala) Ltd. 0.00 0.00 Aarey Drugs & Pharmaceuticals Ltd. 0.33 0.25
    Financial Charges Coverage Ratio Gujarat Inject (Kerala) Ltd. 12521.50 861.55 Aarey Drugs & Pharmaceuticals Ltd. 2.65 2.73
    Current Ratio Gujarat Inject (Kerala) Ltd. 0.64 6.17 Aarey Drugs & Pharmaceuticals Ltd. 2.78 2.32
    Dividend per share Gujarat Inject (Kerala) Ltd. 0.00 0.00 Aarey Drugs & Pharmaceuticals Ltd. 0.00 0.00

    Way2Wealth Brokers Private Limited - CIN U67120KA2000PTC027628 Stock Broking: SEBI Regn No.: INZ000178638 | Exchange Membership ID: NSE: 11502, BSE: 3117, MSEI:51000, MCX: 56730 Depository Participant: SEBI Regn No. IN-DP-472-2020 | CDSL ID: 12062900 & 12031500, NSDL ID: IN303077 | Research Analyst: SEBI Regn No. INH200008705 | PMS: SEBI Regn No.INP000000829 | Register with AMFI ARN: 77558 (Date of Initial registration - 8th Dec 2009, Date of expiry - 24th Jan 2027) | PFRDA: POP226012019

    Way2Wealth Commodities Private Limited - CIN U51229KA2006PTC039880 Stock Broking: SEBI Regn No.: INZ000049130 | Exchange Membership ID: NCDEX : 00908

    Copyrights @ 2014 © Way2Wealth Brokers Pvt. Ltd. All rights reserved

    Designed, developed and content provided by  Dion
    Filing of complaints through SEBI’s online portal ‘SCORES’ and ‘SMARTODR portal’ - Easy & Quick
    A. Register On SCORES / SMARTODR Portal
    B. Mandatory Details For filling Complaints on SCORES: (Name, PAN, Address, Mobile Number, Email ID)
    C. Benefits:

    i. Effective Communication

    ii. Speedy Redressal of Grievance / Dispute